In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Rohith BattinaLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0009-0008-7331-7072 Candace MainorLombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC 20006, USA.
Marcel O SchmidtLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0002-3991-2766 Gregory T GallanisLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0002-9207-7579 Ghada M SharifLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0001-5344-3575 Elaine WalshLombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC 20006, USA.
Kristen WhitakerMedStar Georgetown Cancer Institute, Washington Hospital Center, Washington, DC 20057, USA.
Ian GreenwaltBreast Surgical Oncology, Community Health Haymarket, University of Virginia, Charlottesville, VA 22903, USA.
Lucy De La CruzLombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC 20006, USA.
Nicole SwansonLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0009-0007-1851-3938 Kerrie B BoukerLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0002-4896-9692 Anton WellsteinLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0002-0570-4950 Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.
Paula R PohlmannDepartment of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0001-7914-5162 Anna T RiegelLombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.ORCID 0000-0001-6585-8612 Funding
Pfizer WI223281
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CDK4/6 inhibitorscell cycle progressioncellular deconvolution analysisDuctal carcinoma in situneoadjuvant therapypalbociclibRNA-seq analysis
Identifiers
PMID42649946
PMCPMC13511700
What OpenQuestion holds
Textmetadata
Read underepoch 390